Exogenesis Corporation, based in Billerica, MA, is a leading provider of nanoscale surface modification technology. Their proprietary NanoAccel Gas Cluster Ion Beam (GCIB) and Accelerated Neutral Atom Beam (ANAB) technologies allow for atomic level surface modification without the need for coatings or additives. With exclusive worldwide rights to GCIB intellectual property for biomedical applications, Exogenesis specializes in the development and commercialization of nanoscale surface processing for semiconductors, opto-electronic devices, and medical devices.
Exogenesis has made significant advancements in the field of medical devices, particularly in the area of soft tissue repair. Their patented ANAB technology has been utilized in the creation of innovative products such as the Exogenesis Hernia Mesh and PEEK spinal interbody fusion devices. These devices feature nanotextured surfaces that enhance tissue compatibility and promote successful implant integration. With a focus on collaborative research and commercialization, Exogenesis is actively seeking partnerships to further advance their nanoscale surface modification technology.
Generated from the website